Bed Bath & Beyond (BBBY) Given a $22.00 Price Target by Morgan Stanley Analysts

Bed Bath & Beyond (NASDAQ:BBBY) has been assigned a $22.00 price target by investment analysts at Morgan Stanley in a report issued on Wednesday. The brokerage presently has a “sell” rating on the retailer’s stock. Morgan Stanley’s price target would suggest a potential downside of 4.06% from the stock’s previous close.

A number of other equities analysts have also recently issued reports on the company. Robert W. Baird reiterated a “neutral” rating and issued a $23.00 price objective (down from $28.00) on shares of Bed Bath & Beyond in a report on Monday, September 18th. Zacks Investment Research cut Bed Bath & Beyond from a “buy” rating to a “hold” rating in a report on Wednesday, August 30th. Moffett Nathanson initiated coverage on Bed Bath & Beyond in a report on Monday, December 4th. They issued a “neutral” rating for the company. KeyCorp cut their price objective on Bed Bath & Beyond from $21.00 to $17.00 and set an “underweight” rating for the company in a report on Wednesday, November 15th. Finally, ValuEngine upgraded Bed Bath & Beyond from a “hold” rating to a “buy” rating in a report on Friday, December 1st. Seven equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $26.24.

Bed Bath & Beyond (BBBY) opened at $22.93 on Wednesday. Bed Bath & Beyond has a fifty-two week low of $19.07 and a fifty-two week high of $42.35. The company has a quick ratio of 0.31, a current ratio of 1.67 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $3,280.00, a PE ratio of 6.59, a PEG ratio of -3.73 and a beta of 1.10.

Bed Bath & Beyond (NASDAQ:BBBY) last posted its quarterly earnings data on Wednesday, December 20th. The retailer reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. Bed Bath & Beyond had a return on equity of 19.07% and a net margin of 4.11%. The firm had revenue of $2.95 billion during the quarter, compared to analysts’ expectations of $2.90 billion. During the same period in the prior year, the business earned $0.85 EPS. The company’s revenue for the quarter was down 1.4% compared to the same quarter last year. research analysts anticipate that Bed Bath & Beyond will post 3 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Bronfman E.L. Rothschild L.P. lifted its holdings in Bed Bath & Beyond by 928.4% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,836 shares of the retailer’s stock worth $117,000 after buying an additional 3,463 shares during the period. Ffcm LLC lifted its holdings in Bed Bath & Beyond by 2,958.6% in the 3rd quarter. Ffcm LLC now owns 4,435 shares of the retailer’s stock worth $104,000 after buying an additional 4,290 shares during the period. Cambridge Investment Research Advisors Inc. purchased a new stake in Bed Bath & Beyond in the 2nd quarter worth approximately $251,000. Psagot Investment House Ltd. purchased a new stake in Bed Bath & Beyond in the 3rd quarter worth approximately $217,000. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new stake in Bed Bath & Beyond in the 3rd quarter worth approximately $222,000. Institutional investors and hedge funds own 91.72% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This article was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://www.com-unik.info/2017/12/28/bed-bath-beyond-bbby-given-a-22-00-price-target-by-morgan-stanley-analysts.html.

About Bed Bath & Beyond

Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).

Analyst Recommendations for Bed Bath & Beyond (NASDAQ:BBBY)

Receive News & Ratings for Bed Bath & Beyond Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit